Cleared Traditional

K840706 - ASPARTATE AMINOTRANSFERASE REAGENT

K840706 is the FDA 510(k) clearance for ASPARTATE AMINOTRANSFERASE REAGENT by American Dade. It is a Class 2 Hematology device (product code CIT) cleared through the Traditional 510(k) pathway after a 47-day FDA review.

K840706 · American Dade · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1984
Decision
47d
Days
Class 2
Risk

K840706 is an FDA 510(k) clearance for the ASPARTATE AMINOTRANSFERASE REAGENT. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by American Dade (Mchenry, US). The FDA issued a Cleared decision on April 4, 1984 after a review of 47 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.1100 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Dade devices

Submission Details

510(k) Number K840706 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 1984
Decision Date April 04, 1984
Days to Decision 47 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 113d · This submission: 47d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 105
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K840706.
SIGMA 58-UV ASPARTATE AMINOTRANSFERAS
K842411 · Sigma Chemical Co. · Aug 1984
ASPARTATE AMINOTRANSFERASE ASSAY KIT
K842245 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
SGOT-UV REAGENT SET
K841066 · Medical Specialties, Inc. · May 1984
FLOW-PAC SGOT REAGENT
K830958 · Amresco, Inc. · May 1983
BECKMAN LIQUID-STAT AST-UV LIQUID
K821433 · Beckman Instruments, Inc. · Jun 1982
ULTRAZYME PLUS GOT, #64953,65033&65034
K821467 · Emd Chemicals, Inc. · Jun 1982